Broek Richard van den

CIK 1431872 · last filed 2025-08-19

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

5

Total Filings

66

Lifetime Open-Market Net

$168.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PLSE Director $24.37 $0 6 2025-08-19
CRVS Director $11.93 $0 1 2025-04-09
PhaseBio Pharmaceuticals Inc (PHAS) Delisted Director $0.07 $0 5 2022-05-20
RESPONSE GENETICS INC (RGDX) Delisted Director 282,700 $150.0K 7 2014-07-11
STANDARD DIVERSIFIED INC. (SDIX) Delisted Director 235,630 $18.6K 8 2012-05-17

Recent Filings · Page 3 of 7

66 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2014-12-23 Sell (S) −25,000 -$27.8K
2014-12-23 Disp (D) −39,900 -$45.1K
2014-12-19 Grant (A) +2,000 $0
2014-12-19 Sell (S) −70,000 -$78.2K
2014-10-03 Grant (A) $0
2014-07-11 RESPONSE GENETICS INC (RGDX) Delisted Grant (A) $0 EDGAR
2014-07-02 Grant (A) $0
2014-02-28 Sell (S) −78,835 -$11.56M
2014-01-06 Grant (A) $0
2013-11-22 RESPONSE GENETICS INC (RGDX) Delisted Grant (A) $0 EDGAR
Showing 2130 of 66
Page 3 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.